Federal Register / Vol. 73, No.
26 / Thursday, February 7, 2008 / Notices
dockets/ac/acmenu.htm, click on the
year 2008 and scroll down to the
appropriate advisory committee link.
Procedure: On March 4, 2008, from 8
a.m. to 5:30 p.m., and on March 5, 2008,
from 8:30 a.m. to 5 p.m., the meeting is
open to the public. Interested persons
may present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before February 19, 2008.
Oral presentations from the public will
be scheduled between approximately 10
a.m. and 10:30 a.m., and between 3:15
p.m. and 3:45 p.m. on March 4, 2008,
and between approximately 9:10 a.m.
and 9:40 a.m., and between 2:15 p.m.
and 2:45 p.m. on March 5, 2008. Those
desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before February
11, 2008. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by February 12, 2008.
Closed Presentation of Data: On
March 5, 2008, from 8 a.m. to 8:30 a.m.,
the meeting will be closed so that the
committee may receive an update from
FDA about devices under evaluation
that may be brought before the
committee in the near future. This
portion of the meeting will be closed
because it involves the discussion and
review of trade secret and/or
confidential information (5 U.S.C.
552b(c)(4)).
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Shirley
Meeks, Conference Management Staff, at
240–276–8931, at least 7 days in
jlentini on PROD1PC65 with NOTICES
advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
http://www.fda.gov/oc/advisory/
VerDate Aug<31>2005 17:02 Feb 06, 2008 Jkt 214001
7311
default.htm for procedures on public
conduct during advisory committee
meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: January 28, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8–2265 Filed 2–6–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, T32 Application.
Date: March 6, 2008.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Nos. 93.172, Human Genome Research,
National Institutes of Health, HHS)
January 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–520 Filed 2–6–08; 8:45 am]
BILLING CODE 4140–01–M
PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. the grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders B.
Date: February 28–29, 2008.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, Historic Fell’s
Point, 888 South Broadway, Baltimore, MD
21231.
Contact Person: W. Ernest Lyons, PhD,
Scientific Review Officer, Scientific Review
Branch NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–4056.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Science and
Disorders K.
Date: March 3–4, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Shanta Rajaram, PhD,
Scientific Review Officer, Division of
Extramural Research, NIH/NIND/SRB,
Neuroscience Center, 6601 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20852,
(301) 435–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders A.
Date: March 5–6, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Portofino Hotel, 260 Portofino
Way, Redondo Beach, CA 90277.
Contact Person: Richard D. Crosland, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
07FEN1
 7312 Federal Register / Vol. 73, No. 26 / Thursday, February 7, 2008 / Notices
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd. Suite 3208, MSC 9529,
Bethesda, MD 20892–9529, 301–596–9223.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders C.
Date: March 6–7, 2008.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Melrose Hotel, Washington,
DC., 2430 Pennsylvania Avenue, NW.,
Washington, DC 20037.
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Boulevard, Suite
3208, MSC 9529, Bethesda, MD 20892, (301)
496–0660, benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853. Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: January 31, 2008.
Jennifer Spaeth,
Director of Federal Advisory Committee
Policy.
[FR Doc. 08–517 Filed 2–6–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Diagnostic and
Pharmacokinetic Research in Pediatric HIV/
jlentini on PROD1PC65 with NOTICES
TB and Effects of Co-Infection on the Central
Nervous System (R01).
Date: March 3, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Aug<31>2005 17:02 Feb 06, 2008 Jkt 214001
Place: Gaithersburg Hilton, 620 Perry
Parkway, Gaithersburg, MD 20877.
Contact Person: Sathasiva B. Kandasamy,
PhD, Scientific Review Administrator,
Division of Scientific Review, National
Institutes of Child Health, and Human
Development, 6100 Executive Boulevard,
Room 5B01, Bethesda, MD 20892–9304, 301–
435–6680, skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: January 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–519 Filed 2–6–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and person information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular
Biology of Pathogens.
Date: February 18, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Rolf Menzel, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
MSC 7808, Bethesda, MD 20892, 301–435–
0952, menzelro@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\07FEN1.SGM
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR07–131:
Pharmacogenetics of Fluoride.
Date: February 26, 2008.
Time: 12 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: J. Terrell Hoffeld, DDS,
PhD, Dental Officer, USPHS, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7816, Bethesda, MD 20892, 301–435–
1781, th88q@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Innate
Immunity Overflow Meeting.
Date: February 28–29, 2008.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Samuel C. Edwards, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4200,
MSC 7812, Bethesda, MD 20892, 301–435–
1152, edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, DBBD
Diversity Predoctoral Fellowship Review.
Date: March 4–5, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Paek-Gyu Lee, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4095D,
MSC 7812, Bethesda, MD 20892, 301–402–
7391, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Diversity
Fellowships in Molecular and Cellular
Mechanisms.
Date: March 6–7, 2008.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville Pike, Rockville, MD
20852.
Contact Person: Barbara J. Thomas, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2218,
MSC 7890, Bethesda, MD 20892, 301–435–
0603, bthomas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Biomedical
Mass Spectrometry Shared Instrumentation
Review Panel.
Date: March 12–14, 2008.
Time: 7 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
07FEN1